Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.

Piya RujkijyanontApichat PhotiaChanchai TraivareeChalinee MonsereenusornUsanarat AnurathapanPanya SeksarnDarintr SosothikulPiti TechavichitKleebsabai SanpakitKamon PhuakpetSurapon WiangnonThirachit ChotsampancharoenSu-On ChainansamitSomjai KanjanapongkulArunotai MeekaewkunchornSuradej Hongeng

Published in: BMC cancer (2019)

The topotecan and cyclophosphamide containing induction regimen effectively provides favorable treatment response. The regimen is well tolerated with minimal toxicity among patients with high risk neuroblastoma in Thailand.

Keyphrases

prognostic factors
high dose
low dose
oxidative stress